Copyright Reports & Markets. All rights reserved.

Global Biosynthesis of Cannabinoids Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 THC
      • 1.4.3 CBD
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Biosynthesis of Cannabinoids Market Share by Application (2017-2025)
      • 1.5.2 Food Industry
      • 1.5.3 Medical Industry
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Biosynthesis of Cannabinoids Market Size
    • 2.2 Biosynthesis of Cannabinoids Growth Trends by Regions
      • 2.2.1 Biosynthesis of Cannabinoids Market Size by Regions (2019-2025)
      • 2.2.2 Biosynthesis of Cannabinoids Market Share by Regions (2017-2015)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Key Players

    • 3.1 Biosynthesis of Cannabinoids Revenue by Players (2018-2019)
    • 3.2 Biosynthesis of Cannabinoids Key Players Head office and Area Served
    • 3.3 Key Players Biosynthesis of Cannabinoids Product/Solution/Service
    • 3.4 Date of Enter into Biosynthesis of Cannabinoids Market
    • 3.5 Key Players Biosynthesis of Cannabinoids Funding/Investment Analysis
    • 3.6 Global Key Players Biosynthesis of Cannabinoids Valuation & Market Capitalization
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Biosynthesis of Cannabinoids Market Size by Type (2017-2025)
    • 4.2 Global Biosynthesis of Cannabinoids Market Size by Application (2017-2025)

    5 North America

    • 5.1 North America Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 5.2 Biosynthesis of Cannabinoids Key Players in North America
    • 5.3 North America Biosynthesis of Cannabinoids Market Size by Type
    • 5.4 North America Biosynthesis of Cannabinoids Market Size by Application

    6 Europe

    • 6.1 Europe Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 6.2 Biosynthesis of Cannabinoids Key Players in Europe
    • 6.3 Europe Biosynthesis of Cannabinoids Market Size by Type
    • 6.4 Europe Biosynthesis of Cannabinoids Market Size by Application

    7 China

    • 7.1 China Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 7.2 Biosynthesis of Cannabinoids Key Players in China
    • 7.3 China Biosynthesis of Cannabinoids Market Size by Type
    • 7.4 China Biosynthesis of Cannabinoids Market Size by Application

    8 Japan

    • 8.1 Japan Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 8.2 Biosynthesis of Cannabinoids Key Players in Japan
    • 8.3 Japan Biosynthesis of Cannabinoids Market Size by Type
    • 8.4 Japan Biosynthesis of Cannabinoids Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 9.2 Biosynthesis of Cannabinoids Key Players in Southeast Asia
    • 9.3 Southeast Asia Biosynthesis of Cannabinoids Market Size by Type
    • 9.4 Southeast Asia Biosynthesis of Cannabinoids Market Size by Application

    10 India

    • 10.1 India Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 10.2 Biosynthesis of Cannabinoids Key Players in India
    • 10.3 India Biosynthesis of Cannabinoids Market Size by Type
    • 10.4 India Biosynthesis of Cannabinoids Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Biosynthesis of Cannabinoids Market Forecast (2017-2025)
    • 11.2 Biosynthesis of Cannabinoids Key Players in Central & South America
    • 11.3 Central & South America Biosynthesis of Cannabinoids Market Size by Type
    • 11.4 Central & South America Biosynthesis of Cannabinoids Market Size by Application

    12 International Players Profiles

    • 12.1 Anandia Laboratories
      • 12.1.1 Anandia Laboratories Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Biosynthesis of Cannabinoids Introduction
      • 12.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.1.5 Anandia Laboratories Recent Development
    • 12.2 Gingko Bioworks
      • 12.2.1 Gingko Bioworks Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Biosynthesis of Cannabinoids Introduction
      • 12.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.2.5 Gingko Bioworks Recent Development
    • 12.3 Hyasynth Bio
      • 12.3.1 Hyasynth Bio Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Biosynthesis of Cannabinoids Introduction
      • 12.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.3.5 Hyasynth Bio Recent Development
    • 12.4 InMed Pharmaceuticals
      • 12.4.1 InMed Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Biosynthesis of Cannabinoids Introduction
      • 12.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.4.5 InMed Pharmaceuticals Recent Development
    • 12.5 Librede
      • 12.5.1 Librede Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Biosynthesis of Cannabinoids Introduction
      • 12.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.5.5 Librede Recent Development
    • 12.6 Renew Biopharma
      • 12.6.1 Renew Biopharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Biosynthesis of Cannabinoids Introduction
      • 12.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.6.5 Renew Biopharma Recent Development
    • 12.7 Cronos Group
      • 12.7.1 Cronos Group Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Biosynthesis of Cannabinoids Introduction
      • 12.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.7.5 Cronos Group Recent Development
    • 12.8 Organigram
      • 12.8.1 Organigram Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Biosynthesis of Cannabinoids Introduction
      • 12.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.8.5 Organigram Recent Development
    • 12.9 Teewinot Life Sciences
      • 12.9.1 Teewinot Life Sciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Biosynthesis of Cannabinoids Introduction
      • 12.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.9.5 Teewinot Life Sciences Recent Development
    • 12.10 ICC International Cannabis Corp.
      • 12.10.1 ICC International Cannabis Corp. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Biosynthesis of Cannabinoids Introduction
      • 12.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2019))
      • 12.10.5 ICC International Cannabis Corp. Recent Development
    • 12.11 Biotii Technologies Corp.
    • 12.12 Bristol-Myers Squibb
    • 12.13 Biogen Inc.
    • 12.14 GW Pharmaceuticals

    13 Market Dynamics

    • 13.1 Drivers
    • 13.2 Challenges
    • 13.3 Porter’s Five Forces Analysis
    • 13.4 Market Ecosystem and Value Chain Analysis

    14 Key Findings in This Report

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Biosynthesis of Cannabinoids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosynthesis of Cannabinoids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Anandia Laboratories
      Gingko Bioworks
      Hyasynth Bio
      InMed Pharmaceuticals
      Librede
      Renew Biopharma
      Cronos Group
      Organigram
      Teewinot Life Sciences
      ICC International Cannabis Corp.
      Biotii Technologies Corp.
      Bristol-Myers Squibb
      Biogen Inc.
      GW Pharmaceuticals

      Market segment by Type, the product can be split into
      THC
      CBD
      Others

      Market segment by Application, split into
      Food Industry
      Medical Industry
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Biosynthesis of Cannabinoids status, future forecast, growth opportunity, key market and key players.
      To present the Biosynthesis of Cannabinoids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Biosynthesis of Cannabinoids are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now